Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
The flourishing diabetes market provides a favorable opportunity for the company's growth. Strong solvency appears highly encouraging. However, concerns loom over Tandem Diabetes' substantial reliance on insulin pumps and the impact of macroeconomic challenges. In the past year, this Zacks Rank #3 (Hold) stock has surged 110.9% compared with the 6.1% growth of the industry and a 23.5% rise of the S&P 500 composite. The renowned medical device company has a market capitalization of $3.36 billion. Tandem Diabetes projects an estimated earnings growth rate of 35.2% for 2025 compared with the 9.3% of the S&P 500. In the trailing four quarters, TNDM delivered an average earnings surprise of 9.9%. Let's delve deeper. Tailwinds Impressive Product Innovation Continues: Tandem Diabetes' cutting-edge innovations are creating new possibilities for diabetes management. In 2023, the company initiated a scaled global launch of the Tandem Source data management application, which provides
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating OfficerBusiness Wire
- Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association's 84th Scientific Sessions [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific SessionsBusiness Wire
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Oppenheimer Holdings Inc. from $47.00 to $58.00. They now have an "outperform" rating on the stock.MarketBeat
TNDM
Earnings
- 5/2/24 - Beat
TNDM
Sec Filings
- 6/21/24 - Form 8-K
- 6/20/24 - Form 4
- 6/20/24 - Form 4
- TNDM's page on the SEC website